EMEA News Q4 2020
Latest Full EMEA Member
CONFESQ - Coalición Nacional de Fibromialgia, Síndrome de Fatiga Crónica, Sensibilidad Química Múltiple y Electrohipersensibilidad
Following the European ME Alliance Annual General Meeting (AGM) for 2020 then it is a pleasure to announce that Spanish group (CONFESQ - Coalición Nacional de Fibromialgia, Síndrome de Fatiga Crónica, Sensibilidad Química Múltiple y Electrohipersensibilidad) has been elected as a full member of EMEA.
CONFESQ - National Coalition of FM, SFC, SQM and EHS is a non-profit organization, associative in nature, which was established in 2004, in which National Entities, Regional Federations are registered and, in the case of absence Associations from these regions can also form part of them.
Our commitment is to represent and defend the global rights and interests of people suffering from Fibromyalgia (FM),
Chronic Fatigue Syndrome / Myalgic Encephaliomilitis (CFS / ME), Multiple Chemical Sensitivity (MCS) and Electrohypersensitivity (EHS), as well as their relatives.
This representation is performed both nationally and internationally, integrating and promoting the actions of the entities it represents and those that pursue the same purposes.
Confesq works every day on awareness projects and proposals that improve the quality of life of patients who are affected by any of these diseases.
- Strengthening the Associative Movement: incorporating new entities that favour the development of new associative projects. The Confederation will develop support materials for political, health and social demands.
- Attention to people with educational needs: such as the IRPF subsidy project in 2017 that consists of the creation and implementation of an educational protocol for children, adolescents and young people with this type of disease.
- Awareness campaigns:
More about CONFESQ can be found here.
EMEA are currently receiving applications for membership.
Use the contact link below to apply if you are a European group interested in working with EMEA to create a better future for European ME patients.